6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2019

Commission File Number 000-29338

CORREVIO PHARMA CORP.
(Translation of registrant’s name into English)

1441 Creekside Drive, 6th Floor
Vancouver, BC V6J 4S7
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [   ] Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]

Exhibit	Description
99.1	Notice of meeting and record date for AGSM on June 18, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CORREVIO PHARMA CORP.
		(Registrant)
Date: April 12, 2019	By:	/s/ Justin Renz
	Name:	Justin Renz
	Title:	President and Chief Financial Officer

EX-99.1 2 exhibit99-1.htm NOTICE OF MEETING AND RECORD DATE FOR AGSM ON JUNE 18, 2019

Exhibit 99.1

Date: April 12, 2019	510 Burrard St, 3rd Floor
	Vancouver BC, V6C 3B9
	www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: CORREVIO PHARMA CORP.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type :	Annual General and Special Meeting
Record Date for Notice of Meeting :	May 09, 2019
Record Date for Voting (if applicable) :	May 09, 2019
Beneficial Ownership Determination Date :	May 09, 2019
Meeting Date :	June 18, 2019
Meeting Location (if available) :	Vancouver, BC
Issuer sending proxy related materials directly to NOBO:	Yes
Issuer paying for delivery to OBO:	Yes
Notice and Access (NAA) Requirements:

NAA for Beneficial Holders	No
NAA for Registered Holders	No

Voting Security Details:
Description	CUSIP Number	ISIN
COMMON SHARES	22026V105	CA22026V1058

Sincerely,

Computershare
Agent for CORREVIO PHARMA CORP.

GRAPHIC 3 exhibit99-1x1x1.jpg begin 644 exhibit99-1x1x1.jpg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

EX-99.1

Exhibit 99.1

Date: April 12, 2019	510 Burrard St, 3rd Floor
	Vancouver BC, V6C 3B9
	www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: CORREVIO PHARMA CORP.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type :	Annual General and Special Meeting
Record Date for Notice of Meeting :	May 09, 2019
Record Date for Voting (if applicable) :	May 09, 2019
Beneficial Ownership Determination Date :	May 09, 2019
Meeting Date :	June 18, 2019
Meeting Location (if available) :	Vancouver, BC
Issuer sending proxy related materials directly to NOBO:	Yes
Issuer paying for delivery to OBO:	Yes
Notice and Access (NAA) Requirements:

NAA for Beneficial Holders	No
NAA for Registered Holders	No

Voting Security Details:
Description	CUSIP Number	ISIN
COMMON SHARES	22026V105	CA22026V1058

Sincerely,

Computershare
Agent for CORREVIO PHARMA CORP.